Adjuvant Carboplatin and Paclitaxel Chemotherapy Followed by Radiotherapy in High-Risk Endometrial Cancer: A Retrospective Analysis

PURPOSE: The best adjuvant treatment in high-risk endometrial cancer remains unclear. Although adjuvant chemotherapy seems to improve overall survival (OS) in locally advanced disease, the role of adding radiotherapy is not certain. We evaluated the outcomes of patients with high-risk endometrial ca...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Glob Oncol
Main Authors: Rodrigues da Cunha Colombo Bonadio, Renata, Gondim Meira Velame Azevedo, Renata, Harada, Guilherme, Cabral Severino da Costa, Samantha, Costa Miranda, Vanessa, de Freitas, Daniela, Abdo Filho, Elias, Alves de Oliveira Ferreira, Patricia, Gabrielli, Flavia, Del Pilar Estevez Diz, Maria
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Clinical Oncology 2018
נושאים:
Original Reports
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6223436/
https://ncbi.nlm.nih.gov/pubmed/30241227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JGO.17.00146
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים